The incidence, prevalence and genotype of genital Human Papillomavirus infections in females before and after renal transplantation.

The incidence, prevalence and genotype of genital Human Papillomavirus infections in females before and after renal transplantation. - Genital HPV infections before and after renal transplantation.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON37921

Enrollment

Registered

2012-02-16

Start date

2012-02-28

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genital HPV infection HPV infection of the cervix and vulva

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Female sex; - Age >= 18 years at start of the study; - Eligible for renal transplantation; - Operation at the Radboud University Nijmegen Medical Centre

Exclusion criteria

Exclusion criteria: - Patient not willing to sign and/or return the informed consent form; - Patient refusing additional treatment in case of abnormal findings at the first visit; - Patient being pregnant, or within a period of 3 months after delivery; - Patient being within a period of 3 months after miscarriage.

Design outcomes

Primary

Measure	Time frame
The main study parameter is the prevalence of hr-HPV infections before and after renal transplantation.	—

Secondary

Measure	Time frame
Secondary endpoints are the incidence of HPV infections before and after renal transplantation and the genotype of the HPV infections per time point, and the findings of gynaecological examination before transplantation in relation with the hrHPV status, viral load of a hrHPV infection in time, quality of life before and after transplantation and the correlation of the quality of life with the incidence/prevalence of genital HPV infection/genital (pre)malignant lesions	—

Measure

Time frame

Secondary endpoints are the incidence of HPV infections before and after renal transplantation and the genotype of the HPV infections per time point, and the findings of gynaecological examination before transplantation in relation with the hrHPV status, viral load of a hrHPV infection in time, quality of life before and after transplantation and the correlation of the quality of life with the incidence/prevalence of genital HPV infection/genital (pre)malignant lesions

—

Countries

Netherlands

Outcome results